Carlos Costa

Insider Reports History

Entity
Individual
Location
C/O Foghorn Therapeutics Inc., 500 Technology Square, Suite 700, Cambridge, MA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Carlos Costa
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carlos Costa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief People Officer Stock Option (right to buy) 39.8K $220K $5.52 Sep 23, 2024 Direct
Foghorn Therapeutics Inc. Chief People Officer Common Stock 0 $0 $10.17 Sep 23, 2024 Direct

Insider Reports Filed by Carlos Costa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Sep 20, 2024 6 -$232K 4 Sep 24, 2024 Chief People Officer
FHTX Foghorn Therapeutics Inc. Sep 18, 2024 3 -$73.3K 4 Sep 20, 2024 Chief People Officer
FHTX Foghorn Therapeutics Inc. Sep 16, 2024 6 -$67.4K 4 Sep 18, 2024 Chief People Officer
FHTX Foghorn Therapeutics Inc. Jan 24, 2024 1 $275K 4 Jan 25, 2024 Chief People Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief People Officer
FHTX Foghorn Therapeutics Inc. Aug 1, 2022 0 $0 3/A Sep 9, 2022 Chief People Officer
FHTX Foghorn Therapeutics Inc. Aug 1, 2022 1 $0 4 Aug 3, 2022 Chief People Officer